Samples used for each experiment
| Experiment . | Samples used . |
|---|---|
| RNA-sequencing | AML: 6, 11, 13, 14 |
| ChIP assay | AML: 1, 4, 6 |
| Metabolomics: global | AML: 6, 11, 14 |
| Metabolomics: flux | AML: 4, 5, 6 |
| siRNA experiments | AML: 1, 3, 4, 14 |
| Complex activity assays | AML: 11, 14, 3 |
| MitoSox assay | AML: 5, 6,14 |
| Viability assays LSCs | AML: 5, 6, 14, 11, 15, 16, 17, 18 |
| Colony assays | AML: 1, 2, 4, 6, 11, 13 |
| Patient-derived xenograft ex vivo assays | AML: 1, 6, 11 |
| In vivo assay | AML: 1 |
| Experiment . | Samples used . |
|---|---|
| RNA-sequencing | AML: 6, 11, 13, 14 |
| ChIP assay | AML: 1, 4, 6 |
| Metabolomics: global | AML: 6, 11, 14 |
| Metabolomics: flux | AML: 4, 5, 6 |
| siRNA experiments | AML: 1, 3, 4, 14 |
| Complex activity assays | AML: 11, 14, 3 |
| MitoSox assay | AML: 5, 6,14 |
| Viability assays LSCs | AML: 5, 6, 14, 11, 15, 16, 17, 18 |
| Colony assays | AML: 1, 2, 4, 6, 11, 13 |
| Patient-derived xenograft ex vivo assays | AML: 1, 6, 11 |
| In vivo assay | AML: 1 |